Portola Pharma (PTLA) Tops Q2 EPS by 18c

Portola Pharma (NASDAQ: PTLA) reported Q2 EPS of ($1.02), $0.18 better than the analyst estimate of ($1.20). Revenue for the quarter came in at $4.23 million versus the consensus estimate of $4.38 million.

For earnings history and earnings-related data on Portola Pharma (PTLA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15